Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Understanding the differences between value and growth investing strategies is crucial for your investment approach. Discover more insights here.
25,836 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
As existing-home prices hit record highs, builders in 10 U.S. metro areas are offering discounts on new homes. The mo...
Dreaming of a paycheck you control? This guide breaks down how to start freelancing, find paying clients, price servi...
As investors weigh potential Fed easing, the EDV ETF could surge on falling long-term yields. Here's what to know abo...
Six big forces could redefine how we borrow, buy, and refinance in 2026. This guide breaks down the economy, the hous...
Costco just posted a standout quarter with costco's 9.8% same-store sales showcasing a durable model. This article br...
Celsius has moved into the spotlight as a growth play in beverages. This article lays out five practical reasons Cels...
A clear, practical look at Expedia's Q1 2026 earnings, what drove results, and what to watch next. Learn the segments...
Snowflake delivered a strong fiscal quarter and unveiled a major AWS commitment, sending the stock higher. This guide...
AMD has surged dramatically, but the AI data-center boom could still offer upside. This guide explores whether late a...
When headlines threaten to derail a stock you own, smart investors don’t panic. This guide explains how to evaluate M...
Imagine a world where chair kevin warsh takes the helm of the Fed under a Trump political backdrop. This article brea...